Nuzyra

Active Ingredient(s): Omadacycline Tosylate
FDA Approved: * October 2, 2018
Pharm Company: * PARATEK PHARMS INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nuzyra Overview

Omadacycline (formerly known as PTK-0796)[1] is a broad spectrum antibiotic belonging to the aminomethylcycline subclass[2] of tetracycline antibiotics. In the United States, it was approved in October 2018 for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections. Contents 1 In vitro studies 2 Mechanism of action 3 Clinical trials 4 Discovery 5 References In vitro studies In vitro studies have shown that ...

Read more Nuzyra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Omadacycline

Recent Nuzyra Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Omadacycline Tosylate
  • Powder: 100mg/vial
  • Tablet: 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nuzyra: (2 results)

Sorted by National Drug Code
  • 71715-001 Nuzyra 100 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Paratek Pharmaceuticals, Inc.
  • 71715-002 Nuzyra 150 mg Oral Tablet, Film Coated by Paratek Pharmaceuticals, Inc.

Other drugs which contain Omadacycline Tosylate or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA